Trial intelligence / Profile preview

Alternate vs Daily Iron Supplementation in Premature Babies

NCT06624709Recruiting

Start
Nov 2024
Primary completion
Sep 2026
Modality
Polymer-based Nanoparticles, Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of iron polymaltose in iron deficiency anemia (IDA) (2 arms). Primary endpoint: Anemia at 6 months. Started Nov 2024; status: recruiting.

02

Drugs

iron polymaltose
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on NCT06624709.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06624709.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call